| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/01/2013 | CN101282721B Composition for relieving subjective symptoms of fatigue |
| 05/01/2013 | CN101277705B Agent for amelioration of insulin resistance |
| 05/01/2013 | CN101134036B Preparations containing rebeprazole and sodium bicarbonate and method for preparing the same |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431806 Liposomal formulations of anthracycline agents and cytidine analogs |
| 04/30/2013 | US8431768 Targeted and regional cellular ablation in zebrafish |
| 04/30/2013 | US8431731 Glyceryl and glycol acid compounds |
| 04/30/2013 | US8431715 Thiazole compound (as PPARδ) ligand and pharmaceutical, cosmetic and health food comprised thereof |
| 04/30/2013 | US8431713 2-aminopyridine derivatives as glucokinase activators |
| 04/30/2013 | US8431712 Methods for the synthesis of pyridoxamine |
| 04/30/2013 | US8431708 Fluorescent carbazole compounds for cancer diagnosis |
| 04/30/2013 | US8431706 1,2,3,4-tetrahydroqinoline derivative useful for the treatment of diabetes |
| 04/30/2013 | US8431703 Pyrrolopyridine compounds and their use in treating disease |
| 04/30/2013 | US8431702 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds |
| 04/30/2013 | US8431695 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| 04/30/2013 | US8431617 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
| 04/30/2013 | US8431616 Method for producing a disinfecting agent |
| 04/30/2013 | US8431615 Dose forms |
| 04/30/2013 | US8431614 Loxoprofen derivative and pharmaceutical preparation containing the same |
| 04/30/2013 | US8431613 Memory fixation accelerator |
| 04/30/2013 | US8431611 Artemisinin derivatives |
| 04/30/2013 | US8431610 Alkanoylamino benzamide aniline HDAC inhibitor compounds |
| 04/30/2013 | US8431609 Process for preparation of pyrazole derivatives |
| 04/30/2013 | US8431608 Heterocycles as potassium channel modulators |
| 04/30/2013 | US8431607 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 04/30/2013 | US8431606 Medicament for treating schizophrenia comprising cilostazol |
| 04/30/2013 | US8431605 Modulators of ATP-binding cassette transporters |
| 04/30/2013 | US8431604 Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors |
| 04/30/2013 | US8431603 3-phenylpyrazolo[5,1-b]thiazole compounds |
| 04/30/2013 | US8431602 Beta-amino acid derivatives for treatment of diabetes |
| 04/30/2013 | US8431601 Topical compositions comprising telmesteine for treating dermatological disorders |
| 04/30/2013 | US8431599 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 04/30/2013 | US8431598 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 04/30/2013 | US8431597 Benzimidazole derivatives |
| 04/30/2013 | US8431596 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/30/2013 | US8431595 Furanopyridine cannabinoid compounds and related methods of use |
| 04/30/2013 | US8431594 Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/30/2013 | US8431593 Heteroaryl amide derivatives |
| 04/30/2013 | US8431592 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors |
| 04/30/2013 | US8431591 R(−)-2-methoxy-11-hydroxyaporphine and derivatives thereof |
| 04/30/2013 | US8431590 Spiroindolines as modulators of chemokine receptors |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431588 Cyclopropyl polymerase inhibitors |
| 04/30/2013 | US8431587 Method for the treatment of cancer |
| 04/30/2013 | US8431586 Quinazoline derivatives and pharmaceutical compositions thereof |
| 04/30/2013 | US8431585 Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy |
| 04/30/2013 | US8431584 Heterobicyclic carboxamides as inhibitors for kinases |
| 04/30/2013 | US8431582 Inhibitors of fatty acid uptake and methods of use |
| 04/30/2013 | US8431581 Imidazopyrimidines and uses thereof |
| 04/30/2013 | US8431579 Capped pyrazinoylguanidine sodium channel blockers |
| 04/30/2013 | US8431578 Organic compounds |
| 04/30/2013 | US8431577 Crystalline form of eszopiclone, composition, preparation and uses thereof |
| 04/30/2013 | US8431576 Heterocyclic compounds for the treatment of neurological and psychological disorders |
| 04/30/2013 | US8431575 Phenyl-heteroaryl derivatives and methods of use thereof |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431573 Cyanopyrimidinones |
| 04/30/2013 | US8431572 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours |
| 04/30/2013 | US8431571 Compounds for enzyme inhibition |
| 04/30/2013 | US8431570 Methods of utilizing arylpiperazine derivatives |
| 04/30/2013 | US8431569 Inhibitors of janus kinases |
| 04/30/2013 | US8431568 Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors |
| 04/30/2013 | US8431567 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 04/30/2013 | US8431566 Cyclopamine lactam analogs and methods of use thereof |
| 04/30/2013 | US8431565 Substituted imidazoheterocycles |
| 04/30/2013 | US8431564 Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/30/2013 | US8431562 Crystalline sodium salt of cephalosporin antibiotic |
| 04/30/2013 | US8431561 Methods and compositions for treatment of excess nitric oxide or cyanide toxicity |
| 04/30/2013 | US8431560 Methods of treating hypertriglyceridemia |
| 04/30/2013 | US8431559 Treatment of hot flashes |
| 04/30/2013 | US8431558 Compositions and methods for modification of biomolecules |
| 04/30/2013 | US8431557 Treatment of menopause-associated symptoms |
| 04/30/2013 | US8431556 C-21-keto lupane derivatives preparation and use thereof |
| 04/30/2013 | US8431555 Topical steroidal formulations |
| 04/30/2013 | US8431554 Compound showing anti-inflammatory activity and antiviral activity, pharmaceutical compositions comprising the same, a process for obtaining the same and use of the same in the treatment of epidemic keratoconjunctivites and herpetic stromal keratis |
| 04/30/2013 | US8431553 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 04/30/2013 | US8431552 first agent is an oxidative phosphorylation inhibitor (metformin) or an ionophore or an adenosine 5'-monophosphate-activated Protein kinase (AMPK) activator; second agent is antiinflammatory agent; and an third agent that possesses serotonin activity |
| 04/30/2013 | US8431551 Nutritional composition made using isolated organic matter |
| 04/30/2013 | US8431549 Methods and compositions for administration of iron |
| 04/30/2013 | US8431548 Method for placental exfoliation using oxo-arachidonic acid or the like |
| 04/30/2013 | US8431546 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
| 04/30/2013 | US8431541 Alpha-amylase inhibitors: the montbretins and uses thereof |
| 04/30/2013 | US8431527 Methods for alleviating deleterious effects of 3-deoxyglucosone |
| 04/30/2013 | US8431522 Methods of inhibiting tumor cell proliferation |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431161 Microparticle and pharmaceutical composition thereof |
| 04/30/2013 | US8431159 Solid pharmaceutical dispersions with enhanced bioavailability |
| 04/30/2013 | US8431156 Pharmaceutical composition |
| 04/30/2013 | US8431155 Bromocriptine formulations |
| 04/30/2013 | US8431154 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 04/30/2013 | US8431153 Bioactive composition for the treatment of the HIV/AIDS, method for manufacturing and using the same |
| 04/30/2013 | US8431152 Transdermally absorbable preparation |
| 04/30/2013 | US8431143 Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation |
| 04/30/2013 | US8431141 Alloplastic injectable dermal filler and methods of use thereof |
| 04/30/2013 | US8431140 Topical compositions |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | US8431119 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/30/2013 | US8431114 Polysaccharide-based polymer tissue adhesive for medical use |
| 04/30/2013 | US8431113 Polymer conjugates |
| 04/30/2013 | CA2737851C Controlled release preparation |